Global High-Priority Regulatory Events — February 05, 2026

06-02-2026

Catheter Precision, Inc. filed a multi-item Form 8-K on February 6, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), and amendments to articles of incorporation or bylaws (Item 5.03), with exhibits under Item 9.01. These events suggest potential financing, dilution, and governance changes, but no specific transaction values, share counts, dollar amounts, or financial impacts are disclosed. No positive or negative metrics such as revenue, earnings, or balance sheet effects are mentioned.

06-02-2026

06-02-2026

06-02-2026

Alset Inc. filed an 8-K on February 6, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details such as transaction value, parties involved, strategic rationale, or financial impacts are disclosed.

• ·Filing Accession Number: 0001493152-26-005416
• ·Filing size: 536 KB

06-02-2026

06-02-2026

06-02-2026

06-02-2026

06-02-2026

Cantor Equity Partners VI, Inc. filed a Form 8-K on 2026-02-06 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction values, financial metrics, or performance comparisons provided.

06-02-2026

06-02-2026

06-02-2026

Compass Digital Acquisition Corp. filed an 8-K on 2026-02-06 (AccNo: 0001493152-26-005428) disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. Item 9.01 references financial statements and exhibits. No specific deal terms, financial metrics, parties, valuations, or performance data are disclosed.

06-02-2026

Nine Energy Service, Inc. filed a Form 8-K on 2026-02-06 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. However, the filing also discloses a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, which signals significant compliance issues. Item 9.01 provides financial statements and exhibits, but no quantitative details such as transaction values, impacts, or metrics are disclosed.

06-02-2026

HWH International Inc. filed an 8-K on 2026-02-06 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a financing-related transaction, but no specific dollar values, terms, parties, or financial impacts were disclosed. No positive or negative metrics were provided, limiting assessment of balance sheet or dilution effects.

06-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason for change, or any quantitative metrics are disclosed.

06-02-2026

06-02-2026

Cannabist Co Holdings Inc. filed an 8-K on 2026-02-06 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01, accompanied by Regulation FD disclosure in Item 7.01 and financial statements/exhibits in Item 9.01. No specific transaction details, financial metrics, parties involved, or performance comparisons (positive, negative, or flat) were provided in the filing summary. All key deal terms remain NOT_DISCLOSED.

06-02-2026

ALT5 Sigma Corp filed an 8-K on 2026-02-06 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are disclosed.

06-02-2026

MarketAxess Holdings Inc. filed a Form 8-K on 2026-02-06 reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, percentages, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing indicates significant developments but lacks quantitative data for impact assessment.

06-02-2026

06-02-2026

RXO, Inc. filed a multi-item Form 8-K on February 6, 2026, disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary. Critical quantitative and qualitative details such as impacts, guidance, or scheduled events are NOT_DISCLOSED.

06-02-2026

06-02-2026

Atmus Filtration Technologies Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative metrics, financial data, period-over-period comparisons, or specific details on affected positions, individuals, reasons, or timing are provided. No positive or negative performance metrics are mentioned.

06-02-2026

RenovoRx, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, appointment or resignation, reasons, timing, or individuals involved are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided.

06-02-2026

06-02-2026

SPLASH BEVERAGE GROUP, INC. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

06-02-2026

SmartKem, Inc. filed an 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement (potentially strategic) and under Item 3.02 unregistered sales of equity securities (potentially dilutive). Item 9.01 includes financial statements and exhibits. No transaction details, sizes, financial impacts, or metrics are disclosed.

06-02-2026

Crawford United Corp announced on February 6, 2026, the completion of an acquisition or disposition of assets (Item 2.01), changes in control of the registrant (Item 5.01), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Financial statements and exhibits are included under Item 9.01. No quantitative metrics, deal values, parties involved, or strategic details are disclosed.

06-02-2026

Tharimmune, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the key position affected, individuals involved, reasons for the change, or timing are disclosed. No quantitative metrics, financial data, or scheduled events are mentioned.

06-02-2026

HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 5.08 addresses shareholder nominations pursuant to Exchange Act Rule 14a-11, while Item 8.01 covers other events. No specific names, positions, reasons for changes, financial impacts, or quantitative details are disclosed.

06-02-2026

SunOpta Inc. filed a Form 8-K on 2026-02-06 disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This multi-item filing signals potential strategic developments and leadership changes, but no specific transaction details, personnel names, financial metrics, dollar values, or performance comparisons (positive, negative, or flat) are disclosed. Implications remain uncertain without further details from exhibits or follow-up.

06-02-2026

SpringBig Holdings, Inc. filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013048), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, timing, or compensatory arrangements are disclosed in the provided filing summary. No quantitative data, financial metrics, or other implications are mentioned.

06-02-2026

Anebulo Pharmaceuticals, Inc. filed a Form 8-K on 2026-02-06 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing, which is a material negative event. Item 8.01 reports other events and Item 9.01 includes financial statements and exhibits, but no specific details or quantitative impacts from these items are disclosed. No positive metrics or offsets are mentioned.

06-02-2026

Northfield Bancorp, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details such as officer name, position, reason for change, or any quantitative metrics are disclosed.

06-02-2026

Vroom, Inc. filed an 8-K on 2026-02-06 reporting under Item 1.01 entry into a material definitive agreement, while also disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This represents a multi-item filing with no specific transaction details, dollar values, or terms provided. No positive or negative financial metrics, guidance changes, or strategic context are mentioned.

• ·AccNo: 0001193125-26-040495
• ·File Size: 166 KB
• ·Sector: not specified

06-02-2026

Agape ATP Corp filed a Form 8-K on February 6, 2026 (AccNo: 0001493152-26-005471), disclosing under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing focused on governance and disclosure matters with no quantitative financial metrics, transaction values, or performance comparisons provided in the filing summary. No positive or negative metrics are disclosed.

06-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-06 announcing a Merger/Acquisition event under Item 8.01 Other Events, with Item 9.01 covering Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, or financial terms are disclosed in the filing summary. Sector is not specified, limiting assessment of strategic implications.

06-02-2026

Marriott International Inc. /MD/ filed an 8-K on February 6, 2026 (AccNo: 0001193125-26-041097), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the filing summary. Sector is not specified.

06-02-2026

GBT Technologies Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative data such as compensation amounts were disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or governance implications were mentioned.

06-02-2026

OneWater Marine Inc. filed an 8-K on 2026-02-06 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific transaction details, parties, values, or metrics are disclosed.

06-02-2026

American Drive Acquisition Co filed an 8-K on 2026-02-06 disclosing Item 5.02 on departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers; Item 8.01 on other events; and Item 9.01 on financial statements and exhibits. No merger/acquisition details, quantitative metrics, parties involved, valuations, or strategic rationales are explicitly stated in the filing summary. No positive or negative financial impacts, changes, or comparisons are mentioned.

06-02-2026

Saratoga Investment Corp. filed an 8-K on 2026-02-06 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), along with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction size, terms, or financial impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

06-02-2026

Accuray Inc filed an 8-K on 2026-02-06 reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, indicating a potential removal from US exchange listing. Item 9.01 discloses Financial Statements and Exhibits, but no specific financial metrics, transaction values, or delisting reasons are detailed. No positive developments or offsetting factors are mentioned.

06-02-2026

Waystar Holding Corp. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or timing are disclosed in the provided filing information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.

06-02-2026

GameSquare Holdings, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

06-02-2026

NanoVibronix, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or impacts are disclosed.

06-02-2026

Vivos Therapeutics, Inc. filed an 8-K on February 6, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

06-02-2026

Arcadia Biosciences, Inc. filed an 8-K on 2026-02-06 disclosing an officer or director change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. The filing includes Item 9.01 for financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

06-02-2026

FIRST MERCHANTS CORP filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were provided. No specific details on the affected position, individual, reason, or timing are disclosed.

06-02-2026

PriceSmart Inc. filed an 8-K on February 6, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer change, such as key position affected, appointment or resignation status, reasons, timing, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are explicitly stated.

06-02-2026

MultiSensor AI Holdings, Inc. filed a Form 8-K on 2026-02-06 under Item 1.02 announcing the termination of a material definitive agreement. No financial details, transaction size, parties involved, or impacts on operations or strategy were disclosed. This is a single-item mandatory filing representing a material event by definition.

06-02-2026

PMGC Holdings Inc. filed an 8-K on 2026-02-06 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or performance impacts were disclosed.

06-02-2026

HealthLynked Corp filed an 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 listing financial statements and exhibits. No specific transaction details, dollar values, share counts, financial metrics, or period-over-period comparisons are disclosed in the provided filing summary. The multi-item filing suggests potential dilution from equity sales and increased leverage from financial obligations, but lacks quantification.

06-02-2026

XCF Global, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were provided.

06-02-2026

Acacia Research Corp filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are provided in the filing summary. Sector is not specified.

06-02-2026

ScanTech AI Systems Inc. filed an 8-K on 2026-02-06 disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or strategic context are provided. This multi-item filing signals material corporate actions but lacks specifics on positive or negative implications.

06-02-2026

Grayscale Bitcoin Mini Trust ETF filed an 8-K on 2026-02-06 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing a core material agreement alongside other events, but specific transaction details, parties, dollar values, financial impacts, or metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, guidance changes, or scheduled events are mentioned.

06-02-2026

Travelers Companies, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a leadership event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or financial impacts are provided in the filing summary. This appears to be a standard governance disclosure with no quantitative metrics or period-over-period comparisons mentioned.

06-02-2026

Grayscale Ethereum Mini Trust ETF filed a Form 8-K on 2026-02-06 (AccNo: 0001193125-26-041199, Size: 1 MB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement's parties, terms, value, financial impacts, or strategic context. No quantitative metrics, period-over-period comparisons, positive or negative performance indicators are disclosed.

06-02-2026

Lyra Therapeutics, Inc. filed a Form 8-K on 2026-02-06 under Item 3.01, announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This represents a material negative development with no counterbalancing positive metrics disclosed. No financial details, transaction values, or operational impacts provided.

06-02-2026

Office Properties Income Trust filed an 8-K on 2026-02-06 under Items 1.01 (Entry into a Material Definitive Agreement), 1.03 (Bankruptcy or Receivership), and 9.01 (Financial Statements and Exhibits). The core event is the company's entry into bankruptcy or receivership proceedings, signaling severe financial distress with no disclosed positive offsets or mitigating factors. No quantitative details such as transaction values, financial metrics, or restructuring terms were provided.

• ·AccNo: 0001104659-26-011514
• ·File Size: 1 MB
• ·Event Date: 2026-02-06

06-02-2026

Tempest Therapeutics, Inc. filed an 8-K on 2026-02-06 reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with no specific financial metrics, premiums, or performance changes disclosed. The filing also covers unregistered sales of equity securities (Item 3.02), changes in control of the registrant (Item 5.01), and departures/elections of directors and officers along with compensatory arrangements (Item 5.02). Item 9.01 includes financial statements and exhibits, but details are NOT_DISCLOSED.

06-02-2026

Vistagen Therapeutics, Inc. filed a Form 8-K on 2026-02-06 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This represents a material negative event signaling non-compliance with exchange requirements. No quantitative financial metrics, positive developments, or additional details were disclosed.

06-02-2026

Edgewell Personal Care Co filed an 8-K on February 6, 2026, announcing under Item 2.01 the completion of an acquisition or disposition of assets. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific transaction details, financial metrics, parties involved, or values are disclosed.

06-02-2026

FibroBiologics, Inc. filed a Form 8-K on 2026-02-06 (AccNo: 0001193125-26-041187) under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. File size is 158 KB; sector not specified.

• ·AccNo: 0001193125-26-041187
• ·File size: 158 KB
• ·Sector: not specified

06-02-2026

T1 Energy Inc. filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013301), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

06-02-2026

Hewlett Packard Enterprise Co filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual names, appointment or resignation status, reasons, or compensatory terms are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

06-02-2026

NXP Semiconductors N.V. filed a Form 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are provided in the filing summary.

06-02-2026

GENERATION INCOME PROPERTIES, INC. filed an 8-K on 2026-02-06 (AccNo: 0001193125-26-041188, Size: 62 KB) under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details were disclosed.

06-02-2026

Coupang, Inc. filed a Form 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, or timing are disclosed. This represents a standard SEC-required disclosure for material leadership events with no additional quantitative or qualitative context provided.

06-02-2026

Mohawk Industries Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, individual involved, reason for change, appointment or resignation status, and any compensatory arrangements are NOT_DISCLOSED.

06-02-2026

DANA Inc filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, names, reasons for change, or quantitative impacts are disclosed.

06-02-2026

Commercial Vehicle Group, Inc. filed a Form 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, personnel changes, or disclosures provided in the available information. No quantitative financial impacts, transaction values, or other metrics are disclosed.

06-02-2026

Hennessy Capital Investment Corp. VIII filed a multi-item Form 8-K on February 6, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors or officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, share counts, or named parties beyond the filer are disclosed. This appears to be a mandatory disclosure typical for significant corporate transactions such as potential business combinations.

06-02-2026

Karman Holdings Inc. filed a Form 8-K on February 06, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial terms, or impacts are disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

06-02-2026

Federal Home Loan Mortgage Corp (Freddie Mac) filed an 8-K on February 6, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions, reasons for change, financial terms, or quantitative metrics are mentioned in the provided filing summary. No positive or negative performance metrics are disclosed.

06-02-2026

United Parcel Service Inc filed an 8-K on February 6, 2026 (AccNo: 0001628280-26-006089), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or quantitative data are provided in the filing summary. No other financial metrics, comparisons, or events are mentioned.

06-02-2026

Iris Acquisition Corp II filed an 8-K on February 6, 2026, disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures or elections of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This filing signals a likely merger or acquisition event for the SPAC, consistent with standard de-SPAC processes. No specific deal terms, financial metrics, parties, valuations, or performance changes are disclosed.

06-02-2026

CAPITAL ONE FINANCIAL CORP filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or quantitative impacts are disclosed.

06-02-2026

Owens Corning filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other data points are mentioned.

06-02-2026

Liberty Energy Inc. filed a multi-item Form 8-K on February 6, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, dollar values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. The filing appears timely as the event date matches the filing date.

06-02-2026

ACADIA REALTY TRUST filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, individuals involved, reasons for changes, timing, or any quantitative metrics are disclosed. This appears to be an informational filing with no further context provided.

06-02-2026

Netcapital Inc. filed a Form 8-K on 2026-02-06 under Accession No. 0001493152-26-005589, reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional financial metrics, quantitative data, transaction details, or other items are disclosed. This event indicates a failure to meet listing requirements, with no positive offsets mentioned.

06-02-2026

Lexaria Bioscience Corp. filed a Form 8-K on 2026-02-06 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, transaction values, period-over-period comparisons, or other numerical data disclosed in the available information. This event indicates a material negative development with no offsetting positive metrics reported.

06-02-2026

MANGOCEUTICALS, INC. filed an 8-K on 2026-02-06 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, exchange involved, or impacts are disclosed. Sector is not specified.

• ·Filing Accession Number: 0001493152-26-005587
• ·Filing size: 203 KB

06-02-2026

DESTINATION XL GROUP, INC. filed an 8-K on 2026-02-06 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. No positive or offsetting developments are mentioned.

06-02-2026

M Evo Global Acquisition Corp II filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013321), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition. No quantitative metrics, deal terms, parties involved, valuations, synergies, or performance comparisons—positive or negative—are explicitly stated. Sector details are not specified.

06-02-2026

DT Cloud Star Acquisition Corp filed an 8-K on 2026-02-06 announcing entry into a material definitive agreement under Item 1.01, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This pertains to a Merger/Acquisition event, but specific details including parties involved, deal structure, valuation, terms, and financial metrics are NOT_DISCLOSED. No quantitative data, comparisons, or scheduled events are provided in the filing summary.

06-02-2026

UTG INC filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key position affected (e.g., CEO, CFO), names of individuals, appointment or resignation status, reasons for change, timing, or any financial metrics are explicitly stated. This routine governance filing lacks quantitative data or period-over-period comparisons.

06-02-2026

Regency Centers Corp filed an 8-K on 2026-02-06 disclosing an unspecified officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed.

06-02-2026

Werewolf Therapeutics, Inc. filed a Form 8-K on 2026-02-06 under Item 3.01, announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or future plans were disclosed.

• ·Accession Number: 0001193125-26-041305
• ·File Size: 144 KB
• ·Sector: not specified

06-02-2026

INDEPENDENCE REALTY TRUST, INC. filed an 8-K on 2026-02-06 (AccNo: 0001437749-26-003380) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed.

06-02-2026

Aemetis, Inc. filed an 8-K on February 6, 2026 (AccNo: 0001437749-26-003382, Size: 318 KB), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are provided in the available information.

06-02-2026

Armada Hoffler Properties, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are disclosed. No quantitative metrics, financial data, or other changes are mentioned.

06-02-2026

AgEagle Aerial Systems Inc. filed an 8-K on February 6, 2026 (AccNo: 0001493152-26-005610), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, parties, value, financial impacts, or other quantitative metrics are provided.

06-02-2026

Riley Exploration Permian, Inc. filed an 8-K on February 6, 2026 (AccNo: 0001001614-26-000004), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position, appointment/resignation status, reasons, or any quantitative metrics are disclosed.

06-02-2026

Eaton Corp plc filed an 8-K on 2026-02-06 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory disclosure likely filed timely given the event and filing date alignment. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed.

06-02-2026

Webster Financial Corp filed an 8-K on February 6, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No financial metrics, transaction details, positive or negative impacts, or period-over-period comparisons are disclosed. This is an informational filing with limited specifics available.

06-02-2026

Myseum, Inc. filed an 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits, likely including the agreement details. No specific transaction terms, financial metrics, positive or negative impacts, or other quantitative data are provided in the filing summary.

06-02-2026

Muzero Acquisition Corp filed an 8-K on 2026-02-06 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific deal structure, parties involved, valuation, financial terms, strategic rationale, or quantitative metrics are explicitly stated in the filing summary. Sector is not specified.

06-02-2026

Molina Healthcare, Inc. filed an 8-K on 2026-02-06 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 2.06 material impairments. Item 9.01 provides financial statements and exhibits. The material impairments represent a negative development, while the definitive agreement could have strategic value, though details on all items are not disclosed.

06-02-2026

FOXO Technologies Inc. filed a Form 8-K on February 6, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits provided under Item 9.01. No details on the agreement terms, transaction size, parties involved, or financial impacts are disclosed in the provided information. This multi-item filing appears mandatory due to the triggering events.

06-02-2026

AB International Group Corp. filed a Form 8-K on 2026-02-06 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. This is a multi-item filing indicating significant corporate actions potentially involving financing or strategic transactions. No specific transaction details, dollar values, parties, impacts, or quantitative metrics are disclosed in the provided filing information.

06-02-2026

BioAtla, Inc. filed a Form 8-K on 2026-02-06 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 7.01 provides Regulation FD disclosure. No financial metrics, quantitative data, positive developments, or other details disclosed.

06-02-2026

BioXcel Therapeutics, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including the key position affected, names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.

06-02-2026

Actelis Networks Inc filed an 8-K on 2026-02-06 under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, and transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, exchange involved, or impacts were provided. Sector not specified.

06-02-2026

XMax Inc. filed an 8-K on February 6, 2026 (AccNo: 0001493152-26-005624), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, transaction values, financial impacts, or other metrics are provided in the filing summary.

06-02-2026

VisionWave Holdings, Inc. filed an 8-K on February 6, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
• ·AccNo: 0001731122-26-000189, Size: 257 KB
• ·Sector: NOT_DISCLOSED

06-02-2026

NeoVolta Inc. filed an 8-K on February 6, 2026 (AccNo: 0001683168-26-000848), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector information is not specified.